3Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America [J]. Clin Infect Dis, 2008, 46 (3) : 327- 360.
4Mylonakis E, Barlam TF, Flanigan T, et al. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 case [J]. Chest, 1998, 114 (1):251-262.
6Singh N, Avery RK,Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients[J]. Clin Infect Dis, 2003,36 ( 1 ) : 46-52.
7Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, et al. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients[J]. Intensive Care Med, 2007,33(10): 1694-1703.
8Fortun J, Martin-Davila P, Moreno S, et al. Risk factors for invasive aspergillosis in liver transplant recipients[J]. Liver Tansplant, 2002,8 ( 11 ) : 1065-1070.
9Jantunen E, Piilonen A, Volin L, et al, Diagnostic aspects of invasive aspergillus infections in allogeneic BMT recipients [J]. Bone Marrow Tansplant, 2000, 28(8): 867-871.
10Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis[J]. Chest, 2002,121 (6) : 1988-1999.
